[New studies, new trends: directional coronary atherectomy]

Area of Science:

• Interventional Cardiology
• Cardiovascular Research
• Medical Device Technology

Background:

• Early trials (CAVEAT, CCAT) found no clinical benefit of Directional Coronary Atherectomy (DCA) over Percutaneous Transluminal Coronary Angioplasty (PTCA).
• Theoretical advantages of DCA over PTCA were not demonstrated in initial comparative studies.

Purpose of the Study:

• To evaluate the efficacy of optimized Directional Coronary Atherectomy (DCA) techniques using 7F devices and adjunctive PTCA.
• To compare angiographic restenosis rates between optimized DCA and PTCA.
• To assess the long-term impact of post-procedure CK-MB elevation on mortality in DCA patients.

Main Methods:

• Second-generation trials (OARS, BOAT) employed optimized DCA protocols with 7F devices and adjunctive PTCA.
• Angiographic restenosis rates were compared between DCA and PTCA groups.
• Correlation between post-procedure CK-MB levels and late mortality was analyzed in the DCA cohort.

Main Results:

• Optimized DCA trials (OARS, BOAT) demonstrated lower angiographic restenosis rates compared to earlier trials (CAVEAT).
• Preliminary BOAT results indicated a 20% reduction in angiographic restenosis with DCA versus PTCA.
• No association was found between post-procedure CK-MB elevation and late mortality in patients treated with DCA.

Conclusions:

• Optimized DCA techniques show improved outcomes regarding angiographic restenosis compared to PTCA.
• DCA may become a preferred treatment for specific coronary lesions (ostial, bifurcation) and in-stent restenosis.
• These findings support the expanded clinical application of DCA in routine practice.